Clinical Trial Update: A First-in-human Study of YN001 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 trial of YN001 in healthy volunteers, sponsored by Beijing Inno Medicine, related to cardiovascular diseases, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• YN001

Snippet

Sponsor: Beijing Inno Medicine Co., Ltd. | Conditions: Cardiovascular Diseases | Phase 1 | Status: COMPLETED